The research team identified a critical role for the JAK/STAT pathway in TEN and uncovered JAK/STAT inhibition as a promising curative treatment strategy, with demonstrated recovery in seven patients. This evidence concerns the gene SOAT1 and toxic epidermal necrolysis.